Concepedia

Kevin Hudson

KH

Statistics

Publications

25

Citations

1.5K

H-Index

20

Active since

1971

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (France)

University of Manchester

Babraham Institute

AstraZeneca (United States)

Kevin Hudson is an author at AstraZeneca (United Kingdom) specializing in medicine, drug discovery, and natural sciences.

ORCID

Top concepts

Publications per year

1971–2021

25

Publications

25

Activation of protein kinase B β and γ isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B α

Kay S. Walker, Mária Deák, Andrew D. Paterson et al. · Biochemical Journal · 1998 · 280 citations · Full text

Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS

Sarah J. Ross, Alexey S. Revenko, Lyndsey Hanson et al. · Science Translational Medicine · 2017 · 175 citations

Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation

Richard A. Ward, C. Brassington, Alexander L. Breeze et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

, , +19

Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL

Tabea Erdmann, Pavel Klener, James T. Lynch et al. · Blood · 2017 · 103 citations · Full text

Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

Vera S. Byers, Robert Rodvien, Kathleen A. Grant et al. · PubMed · 1989 · 90 citations

, , +14

1–5 of 25